BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 16006954)

  • 1. Rabbit antithymocyte globulin as induction immunotherapy for pediatric deceased donor kidney transplantation.
    Kamel MH; Mohan P; Little DM; Awan A; Hickey DP
    J Urol; 2005 Aug; 174(2):703-7. PubMed ID: 16006954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rabbit antithymocyte induction and dosing in deceased donor renal transplant recipients over 60 yr of age.
    Patel SJ; Knight RJ; Suki WN; Abdellatif A; Duhart BT; Krauss AG; Mannan S; Nezakatgoo N; Osama Gaber A
    Clin Transplant; 2011; 25(3):E250-6. PubMed ID: 21231963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rabbit antithymocyte globulin. A 10-year experience in cardiac transplantation.
    Copeland JG; Icenogle TB; Williams RJ; Rosado LJ; Butman SM; Vasu MA; Sethi GK; McDonald AN; Klees E; Rhenman MJ
    J Thorac Cardiovasc Surg; 1990 May; 99(5):852-60. PubMed ID: 2329823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rabbit antithymocyte globulin related decrease in platelet count reduced risk of pediatric renal transplant graft thrombosis.
    Kamel MH; Mohan P; Conlon PJ; Little DM; O'Kelly P; Hickey DP
    Pediatr Transplant; 2006 Nov; 10(7):816-21. PubMed ID: 17032428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced dose rabbit anti-thymocyte globulin induction for prevention of acute rejection in high-risk kidney transplant recipients.
    Klem P; Cooper JE; Weiss AS; Gralla J; Owen P; Chan L; Wiseman AC
    Transplantation; 2009 Oct; 88(7):891-6. PubMed ID: 19935460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors and consequences of delayed graft function in deceased donor renal transplant patients receiving antithymocyte globulin induction.
    Patel SJ; Duhart BT; Krauss AG; Moore LW; Egidi MF; Amiri HS; Gaber LW; Gaber AO
    Transplantation; 2008 Jul; 86(2):313-20. PubMed ID: 18645496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Excellent renal allograft survival in donor-specific antibody positive transplant patients-role of intravenous immunoglobulin and rabbit antithymocyte globulin.
    Mai ML; Ahsan N; Wadei HM; Genco PV; Geiger XJ; Willingham DL; Taner CB; Hewitt WR; Grewal HP; Nguyen JH; Hughes CB; Gonwa TA
    Transplantation; 2009 Jan; 87(2):227-32. PubMed ID: 19155977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and economic outcomes of rabbit antithymocyte globulin induction in adults who received kidney transplants from living unrelated donors and received cyclosporine-based immunosuppression.
    Miller JT; Collins CD; Stuckey LJ; Luan FL; Englesbe MJ; Magee JC; Park JM
    Pharmacotherapy; 2009 Oct; 29(10):1166-74. PubMed ID: 19792990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neoquadruple induction with antithymocyte globulin/azathioprine/cyclosporine/prednisolone in simultaneous pancreas and kidney transplant recipients: 8.5-year results.
    Schulz T; Kapischke M; Busing M
    Transplant Proc; 2005 May; 37(4):1815-7. PubMed ID: 15919475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 20-year follow-up results of a randomized controlled trial comparing antilymphocyte globulin induction to no induction in renal transplant patients.
    Cantarovich M; Durrbach A; Hiesse C; Ladouceur M; Benoit G; Charpentier B
    Transplantation; 2008 Dec; 86(12):1732-7. PubMed ID: 19104413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized trial of alemtuzumab versus antithymocyte globulin induction in renal and pancreas transplantation.
    Farney AC; Doares W; Rogers J; Singh R; Hartmann E; Hart L; Ashcraft E; Reeves-Daniels A; Gautreaux M; Iskandar SS; Moore P; Adams PL; Stratta RJ
    Transplantation; 2009 Sep; 88(6):810-9. PubMed ID: 19920781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunosuppression with antithymocyte globulin in renal transplantation: better long-term graft survival.
    Martins L; Fonseca I; Almeida M; Henriques AC; Dias L; Sarmento AM; Cabrita A
    Transplant Proc; 2005; 37(6):2755-8. PubMed ID: 16182802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sirolimus-based triple immunosupression with antithymocyte globulin induction in expanded criteria donor kidney transplantation.
    Uslu A; Nart A; Taşli FA; Postaci H; Aykas A; Doğan M; Sahin T
    Nephrology (Carlton); 2008 Feb; 13(1):80-6. PubMed ID: 18199109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rabbit antithymocyte globulin as induction immunotherapy in pediatric heart transplantation.
    Di Filippo S; Boissonnat P; Sassolas F; Robin J; Ninet J; Champsaur G; Bozio A
    Transplantation; 2003 Feb; 75(3):354-8. PubMed ID: 12589158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized controlled trial of a monoclonal antibody against the interleukin-2 receptor (33B3.1) as compared with rabbit antithymocyte globulin for prophylaxis against rejection of renal allografts.
    Soulillou JP; Cantarovich D; Le Mauff B; Giral M; Robillard N; Hourmant M; Hirn M; Jacques Y
    N Engl J Med; 1990 Apr; 322(17):1175-82. PubMed ID: 2157982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized trial of single-dose versus divided-dose rabbit anti-thymocyte globulin induction in renal transplantation: an interim report.
    Stevens RB; Mercer DF; Grant WJ; Freifeld AG; Lane JT; Groggel GC; Rigley TH; Nielsen KJ; Henning ME; Skorupa JY; Skorupa AJ; Christensen KA; Sandoz JP; Kellogg AM; Langnas AN; Wrenshall LE
    Transplantation; 2008 May; 85(10):1391-9. PubMed ID: 18497677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of induction based on continuous vs discontinuous administration of antithymocyte globulins in renal transplant patients: efficacy and long-term safety.
    Esposito L; Kamar N; Durand D; Rostaing L
    Transplant Proc; 2005 Mar; 37(2):892-4. PubMed ID: 15848567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rabbit antithymocyte globulin is more beneficial in standard kidney than in extended donor recipients.
    Hardinger KL; Brennan DC; Schnitzler MA
    Transplantation; 2009 May; 87(9):1372-6. PubMed ID: 19424038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-dose thymoglobulin use in elderly renal transplant recipients is safe and effective induction therapy.
    Laftavi MR; Patel S; Soliman MR; Alnimri M; Kohli R; Said M; Pankewycz O
    Transplant Proc; 2011 Mar; 43(2):466-8. PubMed ID: 21440735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pediatric renal transplantation: comparative study with renal transplantation in the adult population.
    Parada B; Figueiredo A; Nunes P; Bastos C; Macário F; Roseiro A; Dias V; Rolo F; Mota A
    Transplant Proc; 2005; 37(6):2771-4. PubMed ID: 16182806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.